Axol Bioscience

United Kingdom
unknown
unknown
Stage

About

Axol Bioscience is a biotechnology company that provides contract research services using induced pluripotent stem cell (iPSC) technology to generate diverse human cell types from small tissue samples. It supplies human-relevant in vitro models and custom lab services to support drug discovery in areas such as neurodegeneration, neuroinflammation, and cardiotoxicity for biopharma clients globally.

Explore Axol Bioscience's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.